GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: SMT-026738
Compound class:
Synthetic organic
Comment: SMT-738 is from a novel class of antibacterial compounds that have activity against carbapenem-resistant Enterobacteriaceae (CREs) [1]. The structure is claimed in patent WO2022233886A1 that was filed by Discuva Ltd. (acquired by Summit Therapeutics in 2017) [2]. Functionally, it inhibits LolCDE [1], a complex that is essential for the transport of lipoproteins from the inner membrane to the outer membrane of Gram-negative bacteria.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 2-amino-1-[6-[2-amino-5-(3-methyl-4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methylpropan-1-one |
Synonyms ![]() |
| SMT-026738 |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
SMT-738 |
| Other databases | |
| CAS Registry No. | 2862851-15-6 (source: Scifinder) |
| PubChem CID | 166107891 |
| Search Google for chemical match using the InChIKey | JPOVQSBUKRMDME-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | JPOVQSBUKRMDME |
| UniChem Compound Search for chemical match using the InChIKey | JPOVQSBUKRMDME-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | JPOVQSBUKRMDME-UHFFFAOYSA-N |